Yocheved Brazil
Adult Health · Inwood, NYNPI 1932418621
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.6% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 11.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,230 and has fallen 89.8% since, to $125 in 2024.
Across 78 payments — averaging $24.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$224
- Lilly USA, LLC$178
- AstraZeneca$166
- Bayer$153
- Boehringer Ingelheim$147
- Sobi, Inc$133
- plus $901 from 17 others
What the payments were for
- Food & beverage$1,81896%
- Education$834%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 8 | $224 |
| Lilly USA, LLC | 8 | $178 |
| AstraZeneca(2 entities) | 8 | $166 |
| Bayer | 6 | $153 |
| Boehringer Ingelheim | 6 | $147 |
| Sobi, Inc | 4 | $133 |
| Pfizer | 5 | $133 |
| Incyte Corporation | 4 | $103 |
| Foundation Medicine, Inc. | 3 | $94 |
| Rigel Pharmaceuticals, Inc. | 3 | $89 |
| G1 Therapeutics, Inc. | 3 | $71 |
| Merck | 3 | $66 |
| Astellas Pharma US Inc | 3 | $59 |
| EMD Serono, Inc. | 2 | $47 |
| Puma Biotechnology, Inc. | 2 | $45 |
| Array Biopharma Inc | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| Blueprint Medicines Corporation | 1 | $26 |
| E.r. Squibb & Sons, L.L.C. | 2 | $25 |
| Myriad Genetic Laboratories, Inc. | 1 | $21 |
| Sanofi | 1 | $18 |
| AbbVie | 1 | $17 |
| Seagen Inc. | 1 | $15 |
How this compares
$1,902 in reported general payments places this provider in the 80th percentile of 3,828 adult health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Losartan Potassium | 12 | $104 |
| Sertraline Hcl | 12 | $12 |
Paid to pharmacies, not to this prescriber.
Other adult health in Inwood
- Donna CatameroNew York$279K
- Kristen DurkinPort Jefferson Station$255K
- Mary CiechoskiBuffalo$200K
- Jennifer FioriniGlens Falls$151K
- Katelyn McCormackAmherst$131K
- Maria Gigante-BaggettEast Syracuse$92K
- Jane PattersonRochester$66K
- Alyson HartyNew York$65K
- Danielle BrunoPlainview$61K
- Julie PlantamuraPort Jefferson Station$60K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.